We are live on !
Find out more
XTX Topco Portfolio holdings
AUM
$7.72B
Turnover
39.96%
1-Year Est. Return
32.88%
This Fund
S&P 500
This Quarter Est. Return
+14.41%
1 Year Est. Return
+32.88%
3 Year Est. Return
+87.32%
5 Year Est. Return
+53.71%
10 Year Est. Return
–
AUM
$7.72B
AUM Growth
+$1.97B
(+34%)
Cap. Flow
+$1.58B
Cap. Flow % of AUM
Cap. Flow %
20.47%
Top 10 Holdings %
Top 10 Hldgs %
3.84%
Holding
4,912
New
1,139
Increased
1,694
Reduced
1,253
Closed
824
Avg Time Held
0.5
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$41.2M |
| 2 |
Netflix
NFLX
|
+$35.5M |
| 3 |
Intercontinental Exchange
ICE
|
+$29.7M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$29.4M |
| 5 |
PepsiCo
PEP
|
+$28.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI South Korea ETF
EWY
|
+$35.4M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$29.9M |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$24.6M |
| 4 |
NVIDIA
NVDA
|
+$23.6M |
| 5 |
Arm
ARM
|
+$22.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.1% |
| 2 | Financials | 15.06% |
| 3 | Industrials | 13.66% |
| 4 | Healthcare | 12% |
| 5 | Consumer Discretionary | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3626
Jayud Global Logistics
JYD
$13.3M
| $71.2K | ﹤0.01% |
87,911
+74,463
| +554% | +$191K |
2026 Q1
1 quarter
|
|
3627
Mangoceuticals
MGRX
$4.26M
| $70.8K | ﹤0.01% |
186,256
+173,114
| +1,317% | +$66.7K |
2026 Q1
1 quarter
|
|
3628
Gabelli Convertible and Income Securities Fund
GCV
$76.8M
| $70.6K | ﹤0.01% |
+15,085
| New | +$68.5K |
2026 Q2
0 quarters
|
|
3629
Armata Pharmaceuticals
ARMP
$112M
| $70.2K | ﹤0.01% |
+10,826
| New | +$99.3K |
2026 Q2
0 quarters
|
|
3630
Inhibikase Therapeutics
IKT
$201M
| $69.7K | ﹤0.01% |
34,339
-4,575
| -12% | -$8.19K |
2025 Q4
2 quarters
|
|
3631
Defiance Daily Target 2X Short AMD ETF
DAMD
$201M
| $68.5K | ﹤0.01% |
+4,858
| New | +$275K |
2026 Q2
0 quarters
|
|
3632
Connect Biopharma Holdings
CNTB
$46.1M
| $68.2K | ﹤0.01% |
28,659
-12,469
| -30% | -$30.2K |
2026 Q1
1 quarter
|
|
3633
Douglas Elliman
DOUG
$143M
| $67.9K | ﹤0.01% |
38,337
-26,442
| -41% | -$47.4K |
2025 Q2
4 quarters
|
|
3634
NLI Holdings
NL
$347M
| $67.8K | ﹤0.01% |
+11,395
| New | +$70K |
2026 Q2
0 quarters
|
|
3635
Horizon Technology Finance
HRZN
$265M
| $67.6K | ﹤0.01% |
+14,286
| New | +$61.8K |
2026 Q2
0 quarters
|
|
3636
Microbot Medical
MBOT
$71.9M
| $67.1K | ﹤0.01% |
+34,411
| New | +$70.1K |
2026 Q2
0 quarters
|
|
3637
SIMPPLE Ltd
SPPL
$23.9M
| $67.1K | ﹤0.01% |
+17,245
| New | +$49.7K |
2026 Q2
0 quarters
|
|
3638
Galectin Therapeutics
GALT
$301M
| $66.9K | ﹤0.01% |
+14,422
| New | +$37.4K |
2026 Q2
0 quarters
|
|
3639
Similarweb
SMWB
$742M
| $66.9K | ﹤0.01% |
10,906
-217,974
| -95% | -$793K |
2026 Q1
1 quarter
|
|
3640
Marker Therapeutics
MRKR
$14.9M
| $66.7K | ﹤0.01% |
45,357
-18,210
| -29% | -$26.5K |
2025 Q3
3 quarters
|
|
3641
Metagenomi Therapeutics
MGX
$27.6M
| $66.3K | ﹤0.01% |
55,707
+15,125
| +37% | +$20.2K |
2025 Q3
3 quarters
|
|
3642
BuzzFeed
BZFD
$49.1M
| $66.1K | ﹤0.01% |
45,305
-72,557
| -62% | -$83.4K |
2025 Q2
4 quarters
|
|
3643
PLAYSTUDIOS Inc
MYPS
$56.2M
| $66K | ﹤0.01% |
+13,236
| New | +$63.7K |
2026 Q2
0 quarters
|
|
3644
Pasithea Therapeutics
KTTA
$17.4M
| $65.8K | ﹤0.01% |
127,572
+93,821
| +278% | +$64.5K |
2025 Q3
3 quarters
|
|
3645
Quantum X Labs
QXL
$75.9M
| $65.5K | ﹤0.01% |
+11,498
| New | +$43.5K |
2026 Q2
0 quarters
|
|
3646
Tron Inc
TRON
$640M
| $65.3K | ﹤0.01% |
40,566
+853
| +2% | +$1.72K |
2026 Q1
1 quarter
|
|
3647
PermRock Royalty Trust Unit
PRT
$16.4M
| $65.1K | ﹤0.01% |
+29,048
| New | +$74K |
2026 Q2
0 quarters
|
|
3648
Arq
ARQ
$105M
| $64.9K | ﹤0.01% |
25,448
-47,212
| -65% | -$117K |
2025 Q4
2 quarters
|
|
3649
Gaia
GAIA
$32.5M
| $64.8K | ﹤0.01% |
30,867
+7,244
| +31% | +$18.7K |
2025 Q4
2 quarters
|
|
3650
Air Industries Group
AIRI
$12.9M
| $64.7K | ﹤0.01% |
21,423
-1,308
| -6% | -$4.01K |
2026 Q1
1 quarter
|
|
Similar funds
XTX Topco's Q2 2026 Portfolio in Review
As of Q2 2026, XTX Topco held 4,912 positions worth $7.72B, up 34% from $5.75B the previous quarter. Its ten largest holdings account for 3.8% of the portfolio.
XTX Topco deployed $1.58B of net new capital in Q2 2026, opening 1,139 new positions and adding to 1,694 existing holdings. Its largest new stake was Netflix: 403,127 shares worth $28.8M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $29.9M trimmed.
- XTX Topco's largest Q2 2026 buy was Netflix: 403,127 shares worth $28.8M.
- XTX Topco added most to Chevron in Q2 2026, an estimated $41.2M increase.
- XTX Topco's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $29.9M.
- XTX Topco fully exited iShares MSCI South Korea ETF in Q2 2026, selling an estimated $35.4M.
- XTX Topco's ten largest holdings make up 3.8% of its $7.72B portfolio in Q2 2026.
- XTX Topco opened 1,139 new positions and closed 824 in Q2 2026.
- XTX Topco's portfolio value rose 34% quarter-over-quarter to $7.72B.
Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.